NCT06259253

Brief Summary

The purpose of this research study is to understand barriers to and facilitators of a positive patient experience for Asian patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
520

participants targeted

Target at P75+ for all trials

Timeline
47mo left

Started Apr 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Apr 2024Jul 2030

First Submitted

Initial submission to the registry

January 30, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 24, 2024

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2030

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

6.2 years

First QC Date

January 30, 2024

Last Update Submit

April 28, 2026

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

  • Picker Patient Experience Questionnaire (PPE-15)

    Through study completion; an average of 1 year

Study Arms (2)

Observational Cohort 1 - Patient/Provider

Participant will complete a computer-based questionnaire about your age, gender, income, highest level of education, patient experience, medical mistrust, social support and health care access.

Observational Cohort 2 - Patient/Provider

Participant will complete a computer-based questionnaire about your age, gender, income, highest level of education, patient experience, medical mistrust, social support and health care access.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center Participants

You may qualify if:

  • Self-identify as Asian/Asian American
  • Are 18 years or older
  • Have been diagnosed with cancer, any type
  • Received inpatient care at MD Anderson between 2019 and 2022
  • Have a U.S. address
  • Can read and write in English or simplified Chinese

You may not qualify if:

  • None
  • Self-report as a practicing provider at MD Anderson
  • Provided treatment services to Asian/Asian American patients between 2019 and 2022
  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Lorna McNeill, MPH,PHD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lorna McNeill, MPH,PHD

CONTACT

(713) 563-1103lmcneill@mdanderson.org

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 14, 2024

Study Start

April 24, 2024

Primary Completion (Estimated)

July 1, 2030

Study Completion (Estimated)

July 1, 2030

Last Updated

May 4, 2026

Record last verified: 2026-04

Locations

US(1)